China’s first COVID19 drug has received government approval.
The I.V. drug will work immediately after inoculation and will reduce hospitalization and death by 80 per cent.
The two strongest antibodies were identified and matched to produce the drug.
The I.V. drug will be effective immediately after inoculation, according to Professor Zhang of Qinghua University, a leading figure in the research team.
The medicine will still work against the new Omicron variant, says Zhang.
Unlike previous work, which mainly focused on prevention, the new drug is aimed at treating infections.
The hospitalization and death rates for high-risk populations are expected to decrease by 80%.
